272 related articles for article (PubMed ID: 36175921)
1. Dysfunction and ceRNA network of the tumor suppressor miR-637 in cancer development and prognosis.
Shen J; Liang C; Su X; Wang Q; Ke Y; Fang J; Zhang D; Duan S
Biomark Res; 2022 Sep; 10(1):72. PubMed ID: 36175921
[TBL] [Abstract][Full Text] [Related]
2. miR-33b in human cancer: Mechanistic and clinical perspectives.
Zhang W; Jiang B; Zhu H; Cheng A; Li C; Huang H; Li X; Kuang Y
Biomed Pharmacother; 2023 May; 161():114432. PubMed ID: 36841026
[TBL] [Abstract][Full Text] [Related]
3. CircCCNB1 silencing acting as a miR-106b-5p sponge inhibited GPM6A expression to promote HCC progression by enhancing DYNC1I1 expression and activating the AKT/ERK signaling pathway.
Liu YM; Cao Y; Zhao PS; Wu LY; Lu YM; Wang YL; Zhao JF; Liu XG
Int J Biol Sci; 2022; 18(2):637-651. PubMed ID: 35002514
[No Abstract] [Full Text] [Related]
4. Good or not good: Role of miR-18a in cancer biology.
Kolenda T; Guglas K; Kopczyńska M; Sobocińska J; Teresiak A; Bliźniak R; Lamperska K
Rep Pract Oncol Radiother; 2020; 25(5):808-819. PubMed ID: 32884453
[TBL] [Abstract][Full Text] [Related]
5. The tumor suppressor role and ceRNA network of miR-1294 in cancer.
Mao Y; Shen J; Fang LI; Zhu F; Duan S
Oncol Res; 2023; 31(1):1-12. PubMed ID: 37303740
[TBL] [Abstract][Full Text] [Related]
6. ELF1 activated long non-coding RNA CASC2 inhibits cisplatin resistance of non-small cell lung cancer via the miR-18a/IRF-2 signaling pathway.
Xiao XH; He SY
Eur Rev Med Pharmacol Sci; 2020 Mar; 24(6):3130-3142. PubMed ID: 32271431
[TBL] [Abstract][Full Text] [Related]
7. Dysfunction of miR-802 in tumors.
Gao T; Zou M; Shen T; Duan S
J Clin Lab Anal; 2021 Nov; 35(11):e23989. PubMed ID: 34558723
[TBL] [Abstract][Full Text] [Related]
8. Circular RNA hsa_circ_0008305 (circPTK2) inhibits TGF-β-induced epithelial-mesenchymal transition and metastasis by controlling TIF1γ in non-small cell lung cancer.
Wang L; Tong X; Zhou Z; Wang S; Lei Z; Zhang T; Liu Z; Zeng Y; Li C; Zhao J; Su Z; Zhang C; Liu X; Xu G; Zhang HT
Mol Cancer; 2018 Sep; 17(1):140. PubMed ID: 30261900
[TBL] [Abstract][Full Text] [Related]
9. MiR-29c mediates epithelial-to-mesenchymal transition in human colorectal carcinoma metastasis via PTP4A and GNA13 regulation of β-catenin signaling.
Zhang JX; Mai SJ; Huang XX; Wang FW; Liao YJ; Lin MC; Kung HF; Zeng YX; Xie D
Ann Oncol; 2014 Nov; 25(11):2196-2204. PubMed ID: 25193986
[TBL] [Abstract][Full Text] [Related]
10. The prognostic miR-532-5p-correlated ceRNA-mediated lipid droplet accumulation drives nodal metastasis of cervical cancer.
Shang C; Li Y; He T; Liao Y; Du Q; Wang P; Qiao J; Guo H
J Adv Res; 2022 Mar; 37():169-184. PubMed ID: 35499057
[TBL] [Abstract][Full Text] [Related]
11. Novel Insights into miR-944 in Cancer.
Shen J; Wang Q; Liang C; Su X; Ke Y; Mao Y; Fang J; Duan S
Cancers (Basel); 2022 Aug; 14(17):. PubMed ID: 36077769
[TBL] [Abstract][Full Text] [Related]
12. Long non-coding RNA NORAD contributes to the proliferation, invasion and EMT progression of prostate cancer via the miR-30a-5p/RAB11A/WNT/β-catenin pathway.
Zhang Y; Li Y
Cancer Cell Int; 2020 Nov; 20(1):571. PubMed ID: 33292272
[TBL] [Abstract][Full Text] [Related]
13. AEG-1 3'-untranslated region functions as a ceRNA in inducing epithelial-mesenchymal transition of human non-small cell lung cancer by regulating miR-30a activity.
Liu K; Guo L; Guo Y; Zhou B; Li T; Yang H; Yin R; Xi T
Eur J Cell Biol; 2015 Jan; 94(1):22-31. PubMed ID: 25484183
[TBL] [Abstract][Full Text] [Related]
14. MicroRNA-92a promotes epithelial-mesenchymal transition through activation of PTEN/PI3K/AKT signaling pathway in non-small cell lung cancer metastasis.
Lu C; Shan Z; Hong J; Yang L
Int J Oncol; 2017 Jul; 51(1):235-244. PubMed ID: 28534966
[TBL] [Abstract][Full Text] [Related]
15. A Novel Long Non-coding RNA, MSTRG.51053.2 Regulates Cisplatin Resistance by Sponging the miR-432-5p in Non-small Cell Lung Cancer Cells.
Zhang J; Xu C; Gao Y; Wang Y; Ding Z; Zhang Y; Shen W; Zheng Y; Wan Y
Front Oncol; 2020; 10():215. PubMed ID: 32158694
[No Abstract] [Full Text] [Related]
16. Comprehensive analysis of ceRNA networks to determine genes related to prognosis, overall survival, and immune infiltration in clear cell renal carcinoma.
Chalbatani GM; Momeni SA; Mohammadi Hadloo MH; Karimi Z; Hadizadeh M; Jalali SA; Miri SR; Memari F; Hamblin MR
Comput Biol Med; 2022 Feb; 141():105043. PubMed ID: 34839901
[TBL] [Abstract][Full Text] [Related]
17. LINC01133 as ceRNA inhibits gastric cancer progression by sponging miR-106a-3p to regulate APC expression and the Wnt/β-catenin pathway.
Yang XZ; Cheng TT; He QJ; Lei ZY; Chi J; Tang Z; Liao QX; Zhang H; Zeng LS; Cui SZ
Mol Cancer; 2018 Aug; 17(1):126. PubMed ID: 30134915
[TBL] [Abstract][Full Text] [Related]
18. SH3PXD2A-AS1/miR-330-5p/UBA2 ceRNA network mediates the progression of colorectal cancer through regulating the activity of the Wnt/β-catenin signaling pathway.
Guo S; Zhu KX; Yu WH; Wang T; Li S; Wang YX; Zhang CC; Guo JQ
Environ Toxicol; 2021 Oct; 36(10):1969-1980. PubMed ID: 33073888
[TBL] [Abstract][Full Text] [Related]
19. Long non-coding RNA CASC2 suppresses epithelial-mesenchymal transition of hepatocellular carcinoma cells through CASC2/miR-367/FBXW7 axis.
Wang Y; Liu Z; Yao B; Li Q; Wang L; Wang C; Dou C; Xu M; Liu Q; Tu K
Mol Cancer; 2017 Jul; 16(1):123. PubMed ID: 28716020
[TBL] [Abstract][Full Text] [Related]
20. circ_0007385 served as competing endogenous RNA for miR-519d-3p to suppress malignant behaviors and cisplatin resistance of non-small cell lung cancer cells.
Ye Y; Zhao L; Li Q; Xi C; Li Y; Li Z
Thorac Cancer; 2020 Aug; 11(8):2196-2208. PubMed ID: 32602212
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]